Allen M. Chen, MD
Allen M. Chen, MD, has been appointed the new Joe and Jean Brandmeyer Chair of the Department of Radiation Oncology at the University of Kansas School of Medicine. He will join the faculty on October 1, 2016.
Dr. Chen will succeed Terry Tsue, MD, the Douglas A. Girod, MD, Endowed Professor of Head and Neck Surgical Oncology; Physician-in-Chief for the University of Kansas Cancer Center; and Vice Chair for Administrative Affairs in the Department of Otolaryngology, who has served as Interim Chair since July 2015.
Dr. Chen is currently Professor and Vice Chair of Education in the Department of Radiation Oncology at the University of California, Los Angeles, David Geffen School of Medicine. He is also a member of the Jonsson Comprehensive Cancer Center and serves as Director of the Radiation Oncology Residency Training Program, a position he also previously held at the University of California, Davis, School of Medicine.
Dr. Chen’s research mostly focuses on the use of advanced technologies to optimize cure rates, improve quality of life, and evaluate radiation response of both tumors and normal tissue. He is the principal investigator for several clinical trials combining drugs with radiation, including investigator-initiated translational protocols and cooperative group trials run by the NRG Oncology Group and the Southwestern Oncology Group.
He is currently President-Elect of the Association for Directors of Radiation Oncology Programs and serves on leadership committees for the American Society for Radiation Oncology, the National Cancer Institute, and the American College of Radiology. He has also been the recipient of multiple accolades for teaching, including the Association of Residents in Radiation Oncology Educator of the Year award.
Dr. Chen earned his medical degree from Yale University School of Medicine. He completed residency training in radiology oncology at the MD Anderson Cancer Center and the University of California, San Francisco, School of Medicine. He is board certified in radiation oncology by the American Board of Radiology. ■